Abstract
The purpose of this study was to validate a double-injection (DI) method withN-isopropyl-[123I]p-iodoamphetamine (IMP) to measure regional cerebral blood flow (rCBF) twice in a single session of dynamic SPECT and to elucidate a possible role of this method to identify patients with occlusive disease of major cerebral arteries, who might benefit from cerebral revascularization procedures (CR).Materials and Methods: Fourteen patients with occlusion or severe stenosis of the internal carotid or middle cerebral artery were studied before and after CR to assess hemodynamic changes after revascularization treatment. We quantitatively measured rCBF before and after acetazolamide (ACZ) challenge along with cerebrovascular reserve capacity (CVR) with two injections of IMP in a single session of dynamic SPECT scans (DI method). The reliability and reproducibility of the DI method were validated by menas of a simulation study and in eight patients who were examined without ACZ challenge to measure baseline rCBF twice.Results: The analysis of simulated noisy data with realistic noise levels showed that the errors of the estimates for the first and the second rCBF and for the increase in rCBF were 2.6%, 8.1% and 10.4%, respectively. In the 8 patients examined by the DI method to measure baseline rCBF twice, the mean and the SD of percentage differences between the two consecutive measurements in rCBF were −1.3% and 5.5%, respectively. Eight out of 14 patients with occlusive disease had at least one region with a CVR less than 10%. They showed a significant increase in resting rCBF after CR, not only in the ipsilateral hemisphere (from 26.1±6.4 to 33.4±4.7) but also in the contralateral one (from 28.3±7.0 to 34.7 ±4.7) with a recovery of the ipsilateral CVR from 9.3±17.2 to 41.2±20.1%. The remaining six patients with good-moderate CVR did not show an increase in rCBF after CR (from 28.0±2.7 to 28.3±3.4). The three of them with a moderate CVR (10–25%) before CR showed normalization of CVR after CR.Conclusion: Patients with decreased rCBF and reduced CVR benefited from CR in terms of an increase in rCBF and recovery of CVR. The quantitative double-injection IMP-SPECT has the ability to identify those patients who may benefit from CR.
Similar content being viewed by others
References
Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Nakamura K, Yamamoto Y, et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET.J Neurol Neurosurg Psychiatry 1996; 61: 18–25.
Grubb RL Jr, Derdeyn CP, Fritsch SM, Caepenter DA, Yundt KD, Videen TO, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.JAMA 1998; 280: 1055–1060.
Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases.J Nucl Med 1999; 40: 1992–1998.
Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity.J Neurosurgery 1993; 79: 483–489.
Kleiser B, Widder B. Course of carotid artery occlusions with impaired cerebrovascular reactivity.Stroke 1992; 23: 171–174.
The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial.N Engl J Med 1985; 313: 1191–1200.
Yonekura Y, Nishizawa S, Mukai T, Iwasaki Y, Fukuyama H, Ishikawa M, et al. Functional mapping of flow and back-diffusion rate ofN-isopropyl-p-iodoamphetamine in human brain.J Nucl Med. 1993; 34: 839–844.
Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT.J Nucl Med 1994; 35: 2019–2030.
Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.J Cereb Blood Flow Metab 1994; 14: 763–770.
Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.Am J Neuroradiol 1995; 16: 563–570.
Nishizawa S, Yonekura Y, Tanaka F, Fujita T, Tsuchimochi S, Ishizu K, et al. Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine.J Nucl Med 1995; 36: 1339–1345.
Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion.Neurosurgery 1993; 32: 912–919.
Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhaupl K. Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia.J Neurosurg 1994; 81: 236–244.
Reivich M, Alavi A, Wolf A, Greenberg JH, Fowler J, Christman D, et al. Use of 2-deoxy-d[1-11C]glucose, for the determinationof local cerebral glucose metabolism in humans: variation within and between subjects.J Cereb Blood Flow Metab 1982; 2: 307–319.
Chang JY, Duara R, Barker W, Apicella A, Yoshii F, Kelley RE, et al. Two behavioral states studied in a single PET/FDG procedure: error analysis.J Nucl Med 1989; 30: 93–105.
Podreka I, Baumgartner C, Suess E, Müller C, Brücke T, Lang W, et al. Quantification of regional cerebral blood flow with IMP SPECT. Reproducibility and clinical relevance of flow values.Stroke 1989; 20: 183–191.
Hatazawa J, Iida H, Shimosegawa E, Sato T, Murakami M, Miura Y. Regional cerebral blood flow measurement with iodine-123-IMP autoradiography: normal values, reproducibility and sensitivity to hypoperfusion.J Nucl Med 1997; 38: 1102–1108.
Duara R, Gross-Glenn K, Barker WW, Chang JY, Apicella A, Loewenstein D, et al. Behavioral activation and the variability of cerebral glucose metabolic measurements.J Cereb Blood Flow Metab 1987; 7: 266–271.
Levine RL, Turski PA, Turnipseed WD, Grist T. Extracranial intravascular vasodilatory response to acetazolamide and magnetic resonance angiography.J Neuroimaging 1996; 6: 126–130.
Schreiber WG, Guckel F, Stritzke P, Schmiedek P, Schwartz A, Brix G. Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging.J Cereb Blood Flow. Metab 1998; 18: 1143–1156.
Lythgoe DJ, Williams SC, Cullinane M, Markus HS. Mapping of cerebrovascular, reactivity using BOLD magnetic resonance imaging.Magn Reson Imaging 1999; 17: 495–502.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ueno, M., Nishizawa, S., Toyoda, H. et al. Assessment of cerebral hemodynamics before and after revascularization in patients with occlusive cerebrovascular disease by means of quantitative IMP-SPECT with double-injection protocol. Ann Nucl Med 15, 209–215 (2001). https://doi.org/10.1007/BF02987833
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02987833